Loading [Contrib]/a11y/accessibility-menu.js
Research article Topical Sections

Zein nanocapsules as a tool for surface passivation, drug delivery and biofilm prevention

  • Current oral hygiene treatments focus on managing oral biofilms (i.e. dental plaque) by broad antimicrobial strategies, indiscriminately killing both pathogenic and commensal microorganisms present in the oral cavity. In an effort to identify alternative approaches to antimicrobials, several research groups, including our own, have identified small molecule inhibitors that interrupt cell-cell signaling and biofilm formation, with potential to be selective against pathogens while leaving commensal flora unperturbed. A drawback to such inhibitors is their limited efficacy when used in acute exposures (e.g. mouthwash or brushing). In order to enhance bioavailability and maximize efficacy of these agents in a complex and dynamic environment such as the oral cavity, it is necessary to maintain a constant reservoir of the agents in situ. Therefore, we formulated a biofilm inhibitor delivery system by encapsulating an inhibitor of Streptococcus mutans biofilm formation, S-phenyl-L-cysteine sulfoxide, into zein nanocapsules. Nanocapsules formed 110–235 nm particles in a liquid-liquid dispersion synthesis procedure with S-phenyl-L-cysteine sulfoxide, as determined by dynamic light scattering. The inhibitor-loaded nanocapsules were then used to cast a film and subsequent S. mutans biofilm formation at this surface was studied. Nanocapsule films loaded with biofilm inhibitors were shown to deter early S. mutans biofilm development at 24 h, as well as reduce total viable biofilm-recovered cells at 48 h. This demonstrates proof-of-concept that biofilm inhibitor-loaded zein nanocapsules can reduce S. mutans biofilm growth, and demonstrates a new approach to extend the time that dental plaque inhibitors are present at the tooth surface. This approach has the potential to delay recolonization of the tooth and reduce oral infection/disease.

    Citation: Stephen H. Kasper, Ryan Hart, Magnus Bergkvist, Rabi A. Musah, Nathaniel C. Cady. Zein nanocapsules as a tool for surface passivation, drug delivery and biofilm prevention[J]. AIMS Microbiology, 2016, 2(4): 422-433. doi: 10.3934/microbiol.2016.4.422

    Related Papers:

    [1] Marcelina Cardoso Dos Santos, Cyrille Vézy, Hamid Morjani, Rodolphe Jaffol . Single cell adhesion strength assessed with variable-angle total internal reflection fluorescence microscopy. AIMS Biophysics, 2017, 4(3): 438-450. doi: 10.3934/biophy.2017.3.438
    [2] Min Zhang, Shijun Lin, Wendi Xiao, Danhua Chen, Dongxia Yang, Youming Zhang . Applications of single-cell sequencing for human lung cancer: the progress and the future perspective. AIMS Biophysics, 2017, 4(2): 210-221. doi: 10.3934/biophy.2017.2.210
    [3] Satoru Ito, Kishio Furuya, Masahiro Sokabe, Yoshinori Hasegawa . Cellular ATP release in the lung and airway. AIMS Biophysics, 2016, 3(4): 571-584. doi: 10.3934/biophy.2016.4.571
    [4] Ahmad Sohrabi Kashani, Muthukumaran Packirisamy . Cellular deformation characterization of human breast cancer cells under hydrodynamic forces. AIMS Biophysics, 2017, 4(3): 400-414. doi: 10.3934/biophy.2017.3.400
    [5] Irina A. Zamulaeva, Kristina A. Churyukina, Olga N. Matchuk, Alexander A. Ivanov, Vyacheslav O. Saburov, Alexei L. Zhuze . Dimeric bisbenzimidazoles DB(n) in combination with ionizing radiation decrease number and clonogenic activity of MCF-7 breast cancer stem cells. AIMS Biophysics, 2020, 7(4): 339-361. doi: 10.3934/biophy.2020024
    [6] Oleg A. Karpov, Gareth W. Fearnley, Gina A. Smith, Jayakanth Kankanala, Michael J. McPherson, Darren C. Tomlinson, Michael A. Harrison, Sreenivasan Ponnambalam . Receptor tyrosine kinase structure and function in health and disease. AIMS Biophysics, 2015, 2(4): 476-502. doi: 10.3934/biophy.2015.4.476
    [7] Derrick Lonsdale, Chandler Marrs . The potential of lipid soluble thiamine in the treatment of cancer. AIMS Biophysics, 2020, 7(1): 17-26. doi: 10.3934/biophy.2020002
    [8] Mikayel Ginovyan, Pierre Andreoletti, Mustapha Cherkaoui-Malki, Naira Sahakyan . Hypericum alpestre extract affects the activity of the key antioxidant enzymes in microglial BV-2 cellular models. AIMS Biophysics, 2022, 9(2): 161-171. doi: 10.3934/biophy.2022014
    [9] Zhe Mei, Zhiwen Liu, Zhiguo Zhou . A compact and low cost microfluidic cell impedance detection system. AIMS Biophysics, 2016, 3(4): 596-608. doi: 10.3934/biophy.2016.4.596
    [10] Richard C Petersen . Free-radicals and advanced chemistries involved in cell membrane organization influence oxygen diffusion and pathology treatment. AIMS Biophysics, 2017, 4(2): 240-283. doi: 10.3934/biophy.2017.2.240
  • Current oral hygiene treatments focus on managing oral biofilms (i.e. dental plaque) by broad antimicrobial strategies, indiscriminately killing both pathogenic and commensal microorganisms present in the oral cavity. In an effort to identify alternative approaches to antimicrobials, several research groups, including our own, have identified small molecule inhibitors that interrupt cell-cell signaling and biofilm formation, with potential to be selective against pathogens while leaving commensal flora unperturbed. A drawback to such inhibitors is their limited efficacy when used in acute exposures (e.g. mouthwash or brushing). In order to enhance bioavailability and maximize efficacy of these agents in a complex and dynamic environment such as the oral cavity, it is necessary to maintain a constant reservoir of the agents in situ. Therefore, we formulated a biofilm inhibitor delivery system by encapsulating an inhibitor of Streptococcus mutans biofilm formation, S-phenyl-L-cysteine sulfoxide, into zein nanocapsules. Nanocapsules formed 110–235 nm particles in a liquid-liquid dispersion synthesis procedure with S-phenyl-L-cysteine sulfoxide, as determined by dynamic light scattering. The inhibitor-loaded nanocapsules were then used to cast a film and subsequent S. mutans biofilm formation at this surface was studied. Nanocapsule films loaded with biofilm inhibitors were shown to deter early S. mutans biofilm development at 24 h, as well as reduce total viable biofilm-recovered cells at 48 h. This demonstrates proof-of-concept that biofilm inhibitor-loaded zein nanocapsules can reduce S. mutans biofilm growth, and demonstrates a new approach to extend the time that dental plaque inhibitors are present at the tooth surface. This approach has the potential to delay recolonization of the tooth and reduce oral infection/disease.


    1. Introduction

    Developmentally appropriate genetic signaling depends on internal feedback networks responding to external signals. Recent works have demonstrated that single-cell measurements are key to understanding how these networks respond to external factors because single-cell behavior is rarely normally distributed about a mean value [1,2]. This is partially due to RNA bursting, during which RNA are stochastically produced in the nucleus and after a series of steps arrive in the cytoplasm for translation [1,2]. This spatial separation provides information on the timing of events, even for populations of fixed cells. For example, Neuert et al. measured the single-cell RNA expression of thousands of budding yeasts in response to osmotic shock for multiple genes. Using this dense dataset, they created in silico models that predicted how the internal regulatory networks would respond to new external conditions or genetic perturbations to the network itself [3]. This insight would not be possible using standard ensemble methods because the variability in spatial distribution of RNA and copy number variation in RNA would be lost due to population averaging [1,2,3,4]. This set of techniques provides a powerful tool to image fixed cell populations and infer the temporal sequence of events within a signaling network.

    Vascular development is partially driven by highly proliferative endothelial progenitor cells (EPC). Numerous assays have been utilized to enumerate and isolate EPC by flow cytometry and primary cell culture [5,6,7]. Although conflicting definitions exist in the literature, Critser and Yoder concluded in 2010 that late outgrowth endothelial colony-forming cells (ECFC), which demonstrate the ability for self-renewal and neo-angiogenesis, both in vitro and in animal models, can uniquely be described as progenitors of endothelial cells [6,8]. A key feature of ECFC is tube formation when plated on Matrigel or cross-linked collagen, allowing for the study of in vitro angiogenesis without the need for complicated growth matrices. We previously demonstrated that ECFC are reduced in prematurely born infants that go on to develop bronchopulmonary dysplasia (BPD) and infants born to mothers with preeclampsia [9,10,11]. For prematurely born infants the introduction to room air after birth leads to an increase in environmental oxygen at a developmentally abnormal time.

    One potential regulator of ECFC environmental response to hyperoxia is Thymosin β4 (Tβ4). Cytosolic Tβ4 protein mediates the response of endothelial cells to changes in oxygen environment by modulating the stability of Hypoxia Inducible Factor 1α (HIF-1α). HIF-1α is historically associated with cellular response to hypoxia, not hyperoxia. Recent work has demonstrated a role for HIF-1α in signaling preservation across all changes in oxygen environment, particularly in endothelial cells [12,13,14,15,16]. One key feature of this signaling network is a self-modulating feedback mechanism for Tβ4. Jo et al. demonstrated altered HIF-1α nuclear localization as a function of increasing Tβ4 expression in endothelial cells [12]. Based on these results, we applied high-throughput imaging to determine if changes in the spatial localization of Tβ4 and HIF-1α in ECFC are associated with changes in RNA copy number of vascular endothelial growth factor (vegf) and endothelial nitric oxide synthase (eNOS) at the single-cell level.

    vegf and eNOS are potent pro-proliferation and pro-angiogenesis genes that are associated with many developmental diseases in prematurely born infants [9,17,18,19,20]. Our laboratory previously showed that ECFC derived from the umbilical cord blood of prematurely born infants (pt-ECFC) demonstrated markedly different proliferation in vitro as compared to ECFC derived from the umbilical cord blood of full term birth infants (t-ECFC) [9,10,11]. Based on these results and others, we hypothesized that exposure to hyperoxia introduces a specific environmental signal that blunts pro-proliferation and pro-angiogenesis genetic signaling networks in a sub-population of pt-ECFC. Specifically, we hypothesized that elevated basal cytosolic Tβ4 protein concentration in a subpopulation of pt-ECFC is associated with diminished HIF-1α nuclear localization and diminished early-time (within the first 60 minutes) vegf and eNOS RNA production in response to hyperoxia as compared to t-ECFC.

    To test this hypothesis, we utilized high-throughput single-cell imaging of protein and RNA expression to quantify pt-ECFC and t-ECFC grown in vitro room air and hyperoxia. We quantified Tβ4 and HIF-1α protein expression using immunofluorescence as well as vegf and eNOS RNA expression using single-molecule fluorescence in-situ hybridization (smFISH [21,22]). Because these techniques require cell fixation we were unable to track single-cell temporal correlations. We instead built statistical spatial measures of how independent populations of pt-ECC or t-ECFC respond to either room air or hyperoxia treatment by measuring cell populations across multiple time points and multiple environmental conditions. This allowed us to infer potential casual relationships through statistical analysis.

    We found that pt-ECFC have elevated basal cytosolic Tβ4 as compared to t-ECFC. This was statistically associated with lower HIF-1α nuclear localization. During the first hour of in vitro hyperoxia growth, distinct single-cell populations emerged in pt-ECFC that are not present in t-ECFC. Based on these findings we speculate that this pathway may directly control the pro-angiogenic response of ECFC and propose a set of future experiments.


    2. Materials and Methods


    2.1. Cord blood collection and ECFC isolation

    Cord blood (CB) collection and endothelial colony forming cells (ECFC) were prepared as previously described [23]. CB samples were obtained following informed consent from term (gestational age greater than 37 weeks) and preterm (gestational age less than 36 weeks) infants at the University of Colorado Anschutz Inpatient Pavilion. The Colorado Multiple Institutional Review Board approved all protocols. All CB was processed within 24 hours of collection.

    Mononuclear cells (MNCs) were plated on cell culture plates coated with type 1 rat-tail collagen (BD Biosciences; San Jose, CA) at a density of 5 × 106 cells/cm2. Complete EGM-2 medium (Lonza, CC-3612; with 10% fetal bovine serum) was changed daily for seven days. After seven days, media were changed three times per week and ECFC colonies were enumerated on day 14 using light microscopy. To ensure that ECFC were not migrating or being removed during feeding, the removed media from 6 cell wells was re-plated on collagen-coated plates and observed for 14 days. Cells were then collected into cryogenic tubes and frozen under liquid nitrogen until future studies were performed.


    2.2. ECFC in vitro culture

    ECFC were removed from cryo-suspension and studied at passage 3–5 in complete EGM-2 media. Individual #1 cover slips (Corning, 2845-25) were cleaned in ethanol followed by 1 × PBS. ECFC were plated onto coverslips at low density and cultured in either room air with 5% CO2 or 50% O2 with 5% CO2. At 0, 15, 30 or 60 minutes the EGM-2 medium was replaced with 3.7% paraformaldehyde (Sigma, 47608) for 15 minutes, followed by 1 × PBS (Sigma, P5493). All steps were performed within the incubator to ensure a near constant oxygen environment. Following completion of all coverslips, the PBS in each well was exchanged for 70% ethanol (Sigma, 277649).


    2.3. High-throughput single-molecule, single-cell imaging

    Automated imaging was performed using a custom-built microscope, consisting of an Olympus IX71 microscope base, X-Y translation stage (Mad City Labs Microstage), objective piezo (Mad City Labs F200S), oil-immersion 100 × NA1.3 objective (Olympus UPLSAPO 100XO), multi-color LED light source (Lumencor Spectra-X), LED light source specific filter set (Semrock LED-DA/FI/TR/Cy5-4X-A), and a sCMOS camera (Hamamatsu C11400-22CU). Automation and acquisition were performed using MicroManager v1.4 running on a Windows 7 64-bit laptop [24]. Analysis was performed on a computing cluster with 48 cores, 128 gigabytes of RAM, 2 NVidia TITAN GPUs, and hot swappable storage (Titanus Computers). Custom analysis software was used to analyze all data in both ImageJ [19] and MATLAB (Mathworks).

    Fifty image areas, containing at minimum two cells per area, were identified using the automated stage and objective piezo. At each image area, a simple contrast based autofocus routine implemented in MicroManager was used to correct mechanical or thermal drift. Forty axial image planes were acquired at 250 nm spacing, centered around the algorithm selected best focus point. At each focal plane, four independent images were captured, one each for DAPI, Alexa 488, Alexa 561, and Alexa 647 fluorescent labels.


    2.4. Tβ4 and HIF-1α fluorescent labeling

    All fluorescent labeling steps were adapted from previous work by our group and others [20,21,22]. Following overnight permeabilization in 70% ethanol at 4 ℃, coverslips were washed in 2 mL of 1 × PBS at room temperature followed by incubation in blocking buffer (Thermo-Fisher, 37515). Coverslips were incubated in primary antibody (1:100 dilution in 1 × PBS) for Tβ4 (Abcam, ab14335) and HIF-1α (Abcam, ab51608) overnight, washed in 2 mL of 1 × PBS, incubated in secondary antibody (1:100 dilution in 1 × PBS; Abcam, ab175471; Abcam, ab150115) at 37 ℃, and washed in 2 mL of 1 × PBS with 1 drop of pre-mixed DAPI (Life Technologies, R37606).

    The following steps were performed in low light to prevent bleaching. Coverslips were hybridized with 20 μL of GLOX and Phalloidin-Alexa488 (Life Technologies, A22287) for 30 minutes at room temperature and then washed with GLOX buffer for 15 minutes at room temperature. Coverslips were plated on standard microscope slides with 8 μL GLOX plus enzyme (imaging buffer) and nail polish was applied around the coverslip to seal.


    2.5. Tβ4 and HIF-1α image analysis


    2.5.1. GPU-based de-convolution

    Image de-convolution was performed in ImageJ, utilizing software provided by the Butte Group [25], prior to any further image processing steps.


    2.5.2. Cell and nuclei identification

    Custom in-house MATLAB software was utilized to filter and identify individual cells in every image prior to protein analysis [4,26,27]. The user was presented a maximum intensity projection image of the nuclei and actin cytoskeleton fluorescent labels. Each cell was manually circled and recorded until all cells in an image are identified. A watershed algorithm was used to automatically detect the nucleus within each identified cell. Overlapping cells are not included in further data analysis to avoid over-counting. Cell and nuclei outlines are saved as text-files for use later in the analysis.


    2.5.3. Protein detection and quantification

    The basic workflow of protein detection and quantification was: 1. image filtering and 2. corrected total cell fluorescence (CTCF) calculation. In-house MATLAB and ImageJ software were utilized to median filter and then calculate the CTCF value for every cell. The background for CTCF was independently determined for each image.


    2.6. vegf and eNOS RNA labeling


    2.6.1. Single-molecule fluorescence in-situ hybridization

    All hybridization steps were adapted from previous work by our group and others [4,21,22]. Following the overnight permeabilization, coverslips were washed in 2mL of 10% wash buffer for 30 minutes at 37 ℃. Coverslips were incubated with 20 μL of vegf and eNOS probe solution (1:1:1000 in 10% hybridization buffer) for 8 hours at 37 ℃. Both vegf and eNOS probe sets were designed using both in-house and commercially available probe designing technologies (Biosearch Technologies). Following hybridization, coverslips were washed with 10% wash buffer for 30 minutes at 37 ℃ and then incubated in 10% wash buffer with 1 drop pre-mixed DAPI solution (Life Technologies, R37606) in each well for 30 minutes at 37 ℃. Coverslips were then washed with GLOX buffer for 15 minutes at room temperature.


    2.6.2. Hybridization buffers

    10% wash buffer: 5 mL deionized formamide (Ambion, AM9342), 5 mL 20 × SSC (Ambion, AM9763), 40 mL nuclease-free water (Ambion, AM9932). Hybridization buffer: 1 mL deionized formamide (Ambion, AM9342), 10 mg E. coli tRNA (Roche, 10109541001), 1 mL 20× SSC (Ambion, AM9763), 40 μL ultrapure BSA (Ambion, AM2618), 1 g dextran sulfate (Sigma, D8906-50G), 100 μL of 200mM vanadyl-ribonucleoside complex (Sigma, 94742-1ML), nuclease-free water (Ambion, AM9932) to 10mL total solution. GLOX buffer: 100 μL 1M Tris (Ambion, AM9855G), 1mL 20× SSC (Ambion, AM9763), 400 μL of 10% Glucose, 8.5mL nuclease-free water (Ambion, AM9932).


    2.6.3. Imaging preparation

    The following steps were performed in low light to prevent bleaching. Coverslips were hybridized with 20 μL of GLOX and Phalloidin-Alexa488 (Life Technologies, A22287) for 30 minutes at room temperature and then washed with GLOX buffer for 15 minutes at room temperature. Coverslips were plated on standard microscope slides with 8 μL GLOX plus enzyme (imaging buffer) and nail polish was applied around the coverslip to seal.


    2.6.4. Imaging buffer

    GLOX plus enzyme: 1 μL 3.7 mg/mL Glucose Oxidase (Sigma, G7141), 1 μL Catalase (Sigma, C30), 100 μL GLOX buffer.


    2.7. vegf and eNOS image analysis


    2.7.1. GPU-based de-convolution

    Image de-convolution was performed in ImageJ, utilizing software provided by the Butte Group [25], prior to any further image processing steps.


    2.7.2. Cell and nuclei identification

    FISH-QUANT and custom in-house MATLAB software were utilized to filter and identify individual cells in every image prior to RNA analysis [4,26,27] The user was presented a maximum intensity projection image of the nuclei and actin cytoskeleton fluorescent labels. Each cell was manually circled and recorded until all cells in an image are identified. A watershed algorithm was used to automatically detect the nucleus within each identified cell. Overlapping cells were not included in further data analysis to avoid over-counting. Cell and nuclei outlines are saved as text-files for use later in the analysis.


    2.7.3. RNA detection and quantification

    The basic workflow of RNA detection and quantification was: (1) image filtering, (2) spot pre-detection, (3) spot fitting, (4) non-specific versus specific determination, (5) spot assignment to individual cells, (6) batch processing.

    FISH-QUANT was utilized to identify, fit, and quantify individual RNA labeled using smFISH. The details of FISH-QUANT are described in a prior publication [26]. Background fluorescence is typically due to FISH probes that were either not washed out or non-specifically bound during the labeling procedure [4]. FISH-QUANT utilizes a three-dimensional Gaussian to fit each possible spot and the user must discriminate background from specific binding by manual thresholding of several extracted fit parameters (e.g. lateral fit uncertainty, axial fit uncertainty, amplitude of Gaussian).


    2.8. Statistical analysis of imaging results

    Single-cell protein CTCF and RNA distributions were loaded in MATLAB for statistical analysis. Before further analysis, all measurements were divided by the maximum intensity projection of the measurement's corresponding cell compartment area (nucleus, cytoplasm, or total cell). Area normalized marginal distributions were tested for independence using the two sample Kolmogorov Smirnov (K-S) test implemented in the Statistics Toolbox for MATLAB (null hypothesis rejection at α = 0.05). Area normalized marginal distribution independence were tested at each measured time for a given protein or RNA species for all cell types and growth conditions (population response). Additionally, we tested within each protein or RNA species for a specific cell type and growth condition against measure time points (temporal response). Area normalized multivariate joint distributions were tested for independence using the non-parametric and distribution free multivariate distribution distance tests, implemented in the highdim package for MATLAB (null hypothesis rejection at α = 0.05) [28]. This allowed for direct comparison of the non-Gaussian distributions common in single-cell gene expression imaging experiments using a non-parametric test.


    3. Results


    3.1. Cytosolic basal Tβ4 expression in ECFC

    To begin, we tested if pt-ECFC Tβ4 expression was elevated in multiple primary ECFC cultures. To determine Tβ4 expression, we thawed and prepared individual populations of ECFC from four term and four preterm patients. After three to five passages, we fixed each population and labeled for Tβ4 using immunofluorescence. We assessed protein content using corrected total cell fluorescence (CTCF) for the nucleus, cytoplasm, and total cell. We normalized CTCF values by the maximum projection area of the feature of interest to limit copy number variability due to cell size.

    Using Tβ4 expression from at least 200 cells per patient we find that cytosolic Tβ4 protein expression is elevated across pt-ECFC (n = 4 patients) as compared to t-ECFC (n = 4 patients) at basal conditions (Figure 1). We found that total cell and nuclear Tβ4 expression are not statistically different.

    Figure 1. Area normalized Tβ4 CTCF values. t-ECFC (200 cells from each patient, 4 patients) had lower expression than pt-ECFC (200 cells from each patient, 4 patients) after thawing and passage (p = 1.1e-11 using two-sample K-S test).

    3.2. Tβ4 protein expression and HIF-1α protein nuclear localization

    After establishing that pt-ECFC have elevated Tβ4, we moved on to test if pt-ECFC display diminished HIF-1α nuclear localization. While nuclear localization is not a perfect indicator of transcription factor activity, it is a requirement for a transcription factor to be in the nucleus to activate a gene network. To determine protein localization, we cultured a mixture population of the four patients used in Figure 1 in room air or hyperoxia (50% O2). At 0, 15, and 30 minutes of growth we fixed and labeled for both Tβ4 and HIF-1α using immunofluorescence. We assessed protein content in the nucleus, cytoplasm, and total cell using CTCF. We normalized CTCF values by the maximum projection area of the feature of interest to limit copy number variability due to cell size.

    We found that HIF-1α nuclear localization was diminished for pt-ECFC grown in vitro room air or hyperoxia (top 2 rows; blue line; Figure 2A). In contrast, we found that HIF-1α nuclear localization was immediate and sustained for t-ECFC grown in vitro room air and hyperoxia (bottom 2 rows; blue line; Figure 2A). We found that there was minimal difference in Tβ4 protein localization for pt-ECFC grown in vitro room air or hyperoxia versus t-ECFC grown in vitro room air or hyperoxia respectively (top 2 rows versus bottom 2 rows; Figure 2B). This suggests that it was the initial increased concentration in Tβ4, or other factors not measured here, that lead to the observed reduction in nuclear HIF-1α localization for pt-ECFC grown in vitro hyperoxia [12].

    Figure 2. (A) HIF-1α and (B) Tβ4 protein expression. Marginal probability distributions for nuclear (blue) and cytosolic (red) protein expression for pt-ECFC (top 2 rows) and t-ECFC grown (bottom 2 rows) in vitro room air (RA) and hyperoxia (HO) for 0, 15, and 30 minutes for HIF-1α and Tβ4. Nuclear localization of HIF-1α was blunted in pt-ECFC as compared to t-ECFC in hyperoxia (p < 0.01 for all time points, K-S test). Additionally, nuclear and cytoplasmic expression for HIF-1α and Tβ4 was different between in vitro room air and hyperoxia for both pt-ECFC and t-ECFC (p < 0.01 for all time points, K-S test). (C) Representative maximum projection image of pt-ECFC grown in vitro hyperoxia (nucleus—magenta; actin—blue; HIF-1α—green; Tβ4—red).

    3.3. vegf and eNOS RNA expression

    One consequence of reduced HIF-1α nuclear localization was a potential reduction in vegf and eNOS RNA production. We utilized the same experimental design as above but instead labeled for RNA transcripts at each time point. We found the pt-ECFC do not begin production of vegf or eNOS RNA in either room air or hyperoxia until 60 minutes (top 2 rows; blue line; Figure 3A and B). In contrast, we found t-ECFC began and sustained vegf and eNOS RNA production almost immediately (bottom 2 rows; blue line; Figure 3A and 3B). This production resulted in increased mature RNA in the cytoplasm by 60 minutes (bottom 2 rows; red line; Figure 3A and 3B).

    Figure 3. (A) vegf and (B) eNOS RNA expression. Marginal probability distributions for nuclear (blue) and cytosolic (red) single-cell RNA expression for pt-ECFC and t-ECFC grown in vitro room air and hyperoxia for 0, 15, 30, and 60 minutes for vegf and eNOS. Nuclear vegf RNA production began almost immediately in t-ECFC as compared to pt-ECFC for both in vitro room air and hyperoxia (p < 0.01, K-S test). This production resulted in increased cytosolic vegf RNA at 60 minutes in t-ECFC as compared to pt-ECFC (p < 0.01, K-S test). A similar result was observed for eNOS, however with sustained nuclear expression in t-ECFC through 60 minutes for both in vitro room air and hyperoxia (p < 0.01 except for 60-minute time point, K-S test). The exception was at 60 minutes, where pt-ECFC and t-ECFC eNOS expression were statistically indistinguishable (p > 0.05, K-S test). (C) Representative maximum projection image of t-ECFC grown in vitro hyperoxia (nucleus—magenta; actin—blue; vegf—green; eNOS—red).

    3.4. Protein or RNA expression as a function of nucleus to cytoplasm area ratio

    Based on our above findings that there were differences in Tβ4, HIF-1α, vegf, and eNOS marginal distributions both between pt-ECFC and t-ECFC as well as in vitro room air and hyperoxia growth, we utilized our single-cell dataset to construct multi-dimensional distributions. Based on previous findings that the ratio of nuclear area to cytoplasmic area (N:C ratio) may be a marker of proliferating ECFC [29], we plotted the N:C ratio versus Tβ4 CTCF and HIF-1α CTCF (Figure 4A) and N:C ratio versus vegf RNA transcripts and eNOS RNA transcripts (Figure 4B). Unlike the marginal distributions presented in Figures 23, we utilized the total amount of protein or RNA in each cell to simplify the analysis.

    Figure 4. Multivariate (A) protein (x-axis: Tβ4 CTCF normalized by cell area; y-axis: HIF-1α CTCF normalized by cell area; and z-axis: nuclear to cytoplasm area ratio) and (B) RNA (x-axis: vegf RNA transcripts normalized by cell area; y-axis: eNOS RNA transcripts normalized by cell area; and z-axis: nuclear to cytoplasm area ratio) single-cell distributions at each time point for all conditions.

    This analysis provides a visualization of how the four different cell populations evolved over time, fully leveraging the information within this single-cell dataset. pt-ECFC grown in vitro HO (green) demonstrated different behavior from all other populations for both protein (Figure 4A) and RNA (Figure 4B) (p < 0.01, multi-dimensional distance test). A large heterogeneity in both cell size and protein or RNA expression was also apparent using this analysis, supporting the idea that ensemble measurements may be averaging over several different single cell behaviors, masking these differences.


    4. Discussion

    Our analyses suggested that previous observations of blunted proliferation of pt-ECFC in hyperoxia [9,23] may be due to developmentally appropriate levels of pro-growth proteins, such as Tβ4. These levels were elevated as compared to t-ECFC, most likely due to internal and external factors driving ECFC proliferation. Paradoxically, the release of Tβ4 into the cytosol in response to hyperoxia reduced HIF-1α stability in this high-Tβ4 sub-population [12]. That in turn lead to lowered vegf and eNOS RNA production and the emergence of a less progenitor-like population. The overall results of this network motif matched previous ensemble proliferation measurements, but the details are only observable using single-cell methodologies.

    Because these data were "stop-motion" movies of distinct cell populations, we cannot confirm that those cells with elevated Tβ4 were the same cells that emerged with reduced HIF-1α nuclear localization and subsequent lower vegf and eNOS RNA expression. Future experiments that rely on live-cell fluorescent reporters of Tβ4 and HIF-1α protein followed by smFISH measurement of vegf and eNOS RNA may provide key insight into the temporal evolution of these heterogeneous cell populations.


    5. Conclusion

    In this study, we attempted to address our hypothesis that elevated basal cytosolic Tβ4 protein concentration in a subpopulation of pt-ECFC diminishes early-time (within the first 60 minutes) vegf and eNOS RNA production in response to hyperoxia as compared to t-ECFC. Using single-cell imaging, we found statistical evidence that elevated cytosolic Tβ4 in pt-ECFC were associated with diminished HIF-1α nuclear localization and diminished vegf and eNOS RNA copy number. Our data and analyses, combined with previous studies, suggest that Tβ4 may play a key role in determining ECFC vegf and eNOS response to changes in oxygen environment. Our data additionally suggest a role for HIF-1α, further expanding the scope of this key transcription factor to the ECFC hyperoxia response.


    Acknowledgements

    M.A.A. and D.P.S acknowledge startup funding from the University of Colorado Denver College of Liberal Arts and Sciences. G.J.S. acknowledges funding from the National Institute of Health (NHLBI HL68702). C.D.B. acknowledges funding from the National Institutes of Health (K23 HL121090-01A1).


    Conflict of Interest

    All authors declare no conflicts of interest.


    [1] Kolenbrander PE, Palmer RJ, Rickard AH, et al. (2006) Bacterial interactions and successions during plaque development. Periodontol 2000 42: 47–79. doi: 10.1111/j.1600-0757.2006.00187.x
    [2] Marsh PD, Moter A, Devine DA (2011) Dental plaque biofilms: communities, conflict and control. Periodontol 2000 55: 16–35. doi: 10.1111/j.1600-0757.2009.00339.x
    [3] Costerton JW (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318–1322. doi: 10.1126/science.284.5418.1318
    [4] Costalonga M, Herzberg MC (2014) The oral microbiome and the immunobiology of periodontal disease and caries. Immunol Lett 162: 22–38. doi: 10.1016/j.imlet.2014.08.017
    [5] Kumar PS (2013) Oral microbiota and systemic disease. Anaerobe 24: 90–93. doi: 10.1016/j.anaerobe.2013.09.010
    [6] Han YW, Wang X (2013) Mobile microbiome: oral bacteria in extra-oral infections and inflammation. J Dent Res 92: 485–91. doi: 10.1177/0022034513487559
    [7] Scannapieco FA, Cantos A (2016) Oral inflammation and infection, and chronic medical diseases: implications for the elderly. Periodontol 2000 72: 153–175. doi: 10.1111/prd.12129
    [8] Marsh PD (2010) Controlling the oral biofilm with antimicrobials. J Dent 38: S11–S15. doi: 10.1016/S0300-5712(10)70005-1
    [9] Huang R, Li M, Gregory RL (2011) Bacterial interactions in dental biofilm. Virulence 2: 435–444. doi: 10.4161/viru.2.5.16140
    [10] Kasper SH, Samarian D, Jadhav AP, et al. (2014) S-aryl-L-cysteine sulphoxides and related organosulphur compounds alter oral biofilm development and AI-2-based cell-cell communication. J Appl Microbiol 117: 1472–1486. doi: 10.1111/jam.12616
    [11] Liu C, Worthington RJ, Melander C, et al. (2011) A new small molecule specifically inhibits the cariogenic bacterium Streptococcus mutans in multispecies biofilms. Antimicrob Agents Chemother 55: 2679–2687. doi: 10.1128/AAC.01496-10
    [12] He Z, Wang Q, Hu Y, et al. (2012) Use of the quorum sensing inhibitor furanone C-30 to interfere with biofilm formation by Streptococcus mutans and its luxS mutant strain. Int J Antimicrob Agents 40: 30–35. doi: 10.1016/j.ijantimicag.2012.03.016
    [13] Kunze B, Reck M, Dötsch A, et al. (2010) Damage of Streptococcus mutans biofilms by carolacton, a secondary metabolite from the myxobacterium Sorangium cellulosum. BMC Microbiol 10: 199. doi: 10.1186/1471-2180-10-199
    [14] Eguchi Y, Kubo N, Matsunaga H, et al. (2011) Development of an antivirulence drug against Streptococcus mutans: repression of biofilm formation, acid tolerance, and competence by a histidine kinase inhibitor, walkmycin C. Antimicrob Agents Chemother 55: 1475–1484. doi: 10.1128/AAC.01646-10
    [15] Jones MN, Francis SE, Hutchinson FJ, et al. (1993) Targeting and delivery of bactericide to adsorbed oral bacteria by use of proteoliposomes. Biochim Biophys Acta 1147: 251–261. doi: 10.1016/0005-2736(93)90010-W
    [16] Robinson AM, Creeth JE, Jones MN (2000) The use of immunoliposomes for specific delivery of antimicrobial agents to oral bacteria immobilized on polystyrene. J Biomater Sci 11: 1381–1393. doi: 10.1163/156856200744408
    [17] Jones MN (2005) Use of liposomes to deliver bactericides to bacterial biofilms. Methods Enzymol 391: 211–228. doi: 10.1016/S0076-6879(05)91013-6
    [18] Chen F, Liu XM, Rice KC, et al. (2009) Tooth-binding micelles for dental caries prevention. Antimicrob Agents Chemother 53: 4898–4902. doi: 10.1128/AAC.00387-09
    [19] Chen F, Jia Z, Rice KC, et al. (2013) The development of dentotropic micelles with biodegradable tooth-binding moieties. Pharm Res 30: 2808–2817. doi: 10.1007/s11095-013-1105-5
    [20] Chen F, Rice KC, Liu XM, et al. (2010) Triclosan-loaded tooth-binding micelles for prevention and treatment of dental biofilm, Pharm Res 27: 2356–2364.
    [21] Horev B, Klein MI, Hwang G, et al. (2015) pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence. ACS Nano 9: 2390–2404. doi: 10.1021/nn507170s
    [22] Radovic-Moreno AF, Lu TK, Puscasu VA, et al. (2012) Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano 6: 4279–4287. doi: 10.1021/nn3008383
    [23] Hannig M, Hannig C (2010) Nanomaterials in preventive dentistry. Nat Nanotechnol 5: 565–569. doi: 10.1038/nnano.2010.83
    [24] Nie B, Chen T, Liang M, et al. (2010) The use of nanoparticles to control oral biofilm formation. J Dent Res 89: 1175–1186. doi: 10.1177/0022034510377794
    [25] Murdan S (2005) Formulation and characterisation of zein microspheres as delivery vehicles. J Drug Deliv Sci Technol 15: 267–272.
    [26] Shukla R, Cheryan M (2001) Zein: the industrial protein from corn. Ind Crops Prod 13: 171–192. doi: 10.1016/S0926-6690(00)00064-9
    [27] Elzoghby AO, Samy WM, Elgindy NA (2012) Protein-based nanocarriers as promising drug and gene delivery systems. J Control Release 161: 38–49. doi: 10.1016/j.jconrel.2012.04.036
    [28] Regier MC, Taylor JD, Borcyk T, et al. (2012) Fabrication and characterization of DNA-loaded zein nanospheres. J Nanobiotechnology 10: 44. doi: 10.1186/1477-3155-10-44
    [29] Wang HJ, Lin ZX, Liu XM, et al. (2005) Heparin-loaded zein microsphere film and hemocompatibility. J Control Release 105: 120–131. doi: 10.1016/j.jconrel.2005.03.014
    [30] Torres-Giner S, Martinez-Abad A, Ocio MJ, et al. (2010) Stabilization of a nutraceutical omega-3 fatty acid by encapsulation in ultrathin electrosprayed zein prolamine. J Food Sci 75: N69–N79. doi: 10.1111/j.1750-3841.2010.01678.x
    [31] Luo Y, Teng Z, Wang Q (2012) Development of zein nanoparticles coated with carboxymethyl chitosan for encapsulation and controlled release of vitamin D3. J Agric Food Chem 60: 836–843. doi: 10.1021/jf204194z
    [32] Fu JX, Wang HJ, Zhou YQ, et al. (2009) Antibacterial activity of ciprofloxacin-loaded zein microsphere films. Mater Sci Eng C 29: 1161–1166. doi: 10.1016/j.msec.2008.09.031
    [33] Panchapakesan C, Sozer N, Dogan H, et al. (2012) Effect of different fractions of zein on the mechanical and phase properties of zein films at nano-scale. J Cereal Sci 55: 174–182. doi: 10.1016/j.jcs.2011.11.004
    [34] Cady NC, McKean KA, Behnke J, et al. (2012) Inhibition of biofilm formation, quorum sensing and infection in Pseudomonas aeruginosa by natural products-inspired organosulfur compounds. PLoS One 7: e38492. doi: 10.1371/journal.pone.0038492
    [35] Welin J, Wilkins JC, Beighton D, et al. (2004) Protein expression by Streptococcus mutans during initial stage of biofilm formation. Appl Environ Microbiol 70: 3736–3741. doi: 10.1128/AEM.70.6.3736-3741.2004
    [36] Koo H, Hayacibara MF, Schobel BD, et al. (2003) Inhibition of Streptococcus mutans biofilm accumulation and polysaccharide production by apigenin and tt-farnesol, J Antimicrob Chemother 52: 782–789.
    [37] Merritt J, Qi F, Goodman SD, et al. (2003) Mutation of luxS affects biofilm formation in Streptococcus mutans. Infect Immun 71: 1972–1979. doi: 10.1128/IAI.71.4.1972-1979.2003
    [38] Landini P, Antoniani D, Burgess JG, et al. (2010) Molecular mechanisms of compounds affecting bacterial biofilm formation and dispersal. Appl Microbiol Biotechnol 86: 813–823. doi: 10.1007/s00253-010-2468-8
    [39] Whitchurch CB, Tolker-Nielsen T, Ragas PC, et al. (2002) Extracellular DNA required for bacterial biofilm formation. Science 295: 1487–1487. doi: 10.1126/science.295.5559.1487
    [40] Perry JA, Cvitkovitch DG, Levesque CM (2009) Cell death in Streptococcus mutans biofilms: a link between CSP and extracellular DNA. FEMS Microbiol Lett 299: 261–266. doi: 10.1111/j.1574-6968.2009.01758.x
    [41] Allaker RP, Memarzadeh K (2014) Nanoparticles and the control of oral infections. Int J Antimicrob Agents 43: 95–104.
    [42] Melo MAS, Guedes SFF, Xu HHK, et al. (2013) Nanotechnology-based restorative materials for dental caries management. Trends Biotechnol 31: 459–467. doi: 10.1016/j.tibtech.2013.05.010
    [43] Benoit DSW, Koo H (2016) Targeted, triggered drug delivery to tumor and biofilm microenvironments. Nanomedicine 11: 873–879. doi: 10.2217/nnm-2016-0014
    [44] Forier K, Raemdonck K, De Smedt SC, et al. (2014) Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J Control Release 190: 607–623. doi: 10.1016/j.jconrel.2014.03.055
    [45] Torres-Giner S, Ocio MJ, Lagaron JM (2009) Novel antimicrobial ultrathin structures of zein/chitosan blends obtained by electrospinning. Carbohydr Polym 77: 261–266. doi: 10.1016/j.carbpol.2008.12.035
    [46] Del Nobile MA, Conte A, Incoronato AL, et al. (2008) Antimicrobial efficacy and release kinetics of thymol from zein films. J Food Eng 89: 57–63. doi: 10.1016/j.jfoodeng.2008.04.004
    [47] Dawson PL, Hirt DE, Rieck JR, et al. (2003) Nisin release from films is affected by both protein type and film-forming method. Food Res Int 36: 959–968. doi: 10.1016/S0963-9969(03)00116-9
    [48] Sousa FFO, Luzardo-Alvarez A, Pérez-Estévéz A, et al. (2010) Development of a novel AMX-loaded PLGA/zein microsphere for root canal disinfection. Biomed Mater 5: 055008. doi: 10.1088/1748-6041/5/5/055008
    [49] de Sousa FO, Blanco-Méndez J, Pérez-Estévez A, et al. (2012) Effect of zein on biodegradable inserts for the delivery of tetracycline within periodontal pockets. J Biomater Appl 27: 187–200. doi: 10.1177/0885328211398968
    [50] Yun J, Fan X, Li X, et al. (2015) Natural surface coating to inactivate Salmonella enterica serovar Typhimurium and maintain quality of cherry tomatoes. Int J Food Microbiol 193: 59–67. doi: 10.1016/j.ijfoodmicro.2014.10.013
    [51] Lai LF, Guo HX (2011) Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting. Int J Pharm 404: 317–323. doi: 10.1016/j.ijpharm.2010.11.025
    [52] Muthuselvi L, Dhathathreyan A (2006) Simple coacervates of zein to encapsulate Gitoxin. Colloids Surf B Biointerfaces 51: 39–43. doi: 10.1016/j.colsurfb.2006.05.012
    [53] Chen L, Subirade M (2009) Elaboration and characterization of soy/zein protein microspheres for controlled nutraceutical delivery. Biomacromolecules 10: 3327–3334. doi: 10.1021/bm900989y
  • Reader Comments
  • © 2016 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(6856) PDF downloads(1240) Cited by(6)

Article outline

Figures and Tables

Figures(4)

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog